Finances · EXACT THERAPEUTICS AS
Accounts
Company accounts 2012–2025
| NOK 1,000 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | Change from 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating revenue | 59 | — | 4 | 55 | 52 | 0 | 7,428 | 5,580 | 7,860 | 5,084 | 5,207 | 5,761 | 4,070 | 202 | — |
| Operating profit | −84,569 | −52,216 | −47,920 | −41,741 | −60,510 | −34,806 | −15,980 | −7,625 | −4,953 | −1,287 | 516 | −1,024 | −1,153 | −7 | −62.0% |
| Profit before tax | −86,623 | −51,625 | −48,076 | −41,423 | −59,838 | −33,176 | −14,982 | −7,586 | −4,914 | −1,286 | 511 | −1,014 | −1,162 | −7 | −67.8% |
| Net profit | −86,623 | −51,625 | −48,076 | −41,423 | −59,838 | −33,176 | −14,982 | −7,586 | −4,914 | −1,286 | 511 | −1,014 | −1,162 | −7 | −67.8% |
| Total assets | 66,097 | 151,194 | 58,112 | 78,421 | 115,617 | 170,390 | 51,762 | 63,232 | 20,024 | 6,823 | 4,030 | 3,292 | 2,634 | 338 | −56.3% |
| Equity | 44,076 | 128,439 | 42,262 | 62,543 | 104,290 | 159,478 | 42,079 | 57,061 | 8,346 | 760 | −1,654 | −2,165 | −1,151 | 11 | −65.7% |
| Liabilities | 22,020 | 22,755 | 15,850 | 15,878 | 11,327 | 10,912 | 9,683 | 6,171 | 11,678 | 6,063 | 5,684 | 5,457 | 3,785 | 326 | −3.2% |
Source: the Register of Company Accounts, older years via areg.no, read 15 Nov 2026
Group accounts 2023–2025
| NOK 1,000 | 2025 | 2024 | 2023 | Change from 2024 |
|---|---|---|---|---|
| Operating revenue | 59 | 0 | 4 | — |
| Operating profit | −84,877 | −52,855 | −48,379 | −60.6% |
| Profit before tax | −86,968 | −52,332 | −48,382 | −66.2% |
| Net profit | −86,968 | −52,332 | −48,334 | −66.2% |
| Total assets | 67,396 | 153,197 | 61,319 | −56.0% |
| Equity | 30,708 | 115,546 | 45,101 | −73.4% |
| Liabilities | 36,689 | 37,651 | 16,218 | −2.6% |
Assumed: the group figures are after the elimination of internal transactions. Source: the Register of Company Accounts, read 15 Nov 2026